Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
Law firm Wolf Greenfield has hired Jeffrey Hsi as a shareholder in its pharmaceutical practice.   16 November 2015
Americas
Roxane Laboratories’s bid to knock out Prometheus Laboratories's patent covering its Lotronex (alosetron) product has been successful after the US Court of Appeals for the Federal Circuit affirmed that it is invalid.   13 November 2015
Americas
Abbott Laboratories has successfully obtained an injunction against a number of US retailers selling ‘grey good’ strips for diabetics that had been manufactured in Ireland and later sold in the US at a lower price.   12 November 2015
Big Pharma
The patentability of any claims directed to the use of CRISPR technology in human embryo-like structures and human reproductive cells is far from certain, as Duncan Ribbons and Maeve Lynch of Redd explain.   12 November 2015
Americas
Electronic transmissions of data do not count as “articles” under the 1930 Tariff Act and the International Trade Commission overstepped its mark in halting their transmission, the US Court of Appeals for the Federal Circuit has ruled.   11 November 2015
Asia-Pacific
Australia-based law firm Piper Alderman has hired Julian Grover as a special counsel in the firm’s intellectual property practice.   10 November 2015
Europe
The English High Court has granted Warner-Lambert an injunction in its patent dispute with generics company Sandoz and LloydsPharmacy   9 November 2015
Africa
The World Trade Organization has granted permission for the world’s Least Developed Countries to be exempt from administering and enforcing patents directed to pharmaceutical drugs.   6 November 2015
Americas
AstraZeneca has sued Dr. Reddy’s Laboratories claiming that the colour purple, used by DRL on its generic version of AZ’s Nexium (esomeprazole), infringes its trademarks.   5 November 2015
Big Pharma
The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.   4 November 2015